With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...
Hosted on MSN19h
M&A Synergies Drive BSX: Is it Worth Buying the Stock Now?Despite macroeconomic concerns, currency headwinds and related cost inflation, Boston Scientific Corporation BSX is seeing strength across target markets. The company is demonstrating growth backed by ...
Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback